Galectin Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Galectin Therapeutics, Inc. Website Screenshot

http://galectintherapeutics.com

Galectin Therapeutics, Inc. Company Intro

Galectin Therapeutics looks to help patients with NASH cirrhosis and cancer. Galectin’s lead drug (GR-MD-02, or belapectin) is a galectin-3 inhibitor.

Industry

Healthcare

Galectin Therapeutics, Inc. Headquaters

4960 Peachtree Industrial Boulevard
Norcross,30071
United States


Galectin Therapeutics, Inc. Share price

28 Oct 2020 01:41 GMT

$2.6900

0.08 (3.07 %)


Galectin Therapeutics, Inc. Market cap

$149.542 M


WMC RANKING

2020

Galectin Therapeutics, Inc. # 347

Biotechnology



Latest Galectin Therapeutics, Inc. News

News 26 Oct 2020

Galectin 3 Market Provides In-Depth Analysis of the Industry, With Current Trends and Future Estimations to Elucidate The Investment Pockets | (2020-2025)

UMR has published a research report on the Galectin 3 market. The report covers comprehensive ... Bristol-Myers Squibb Company Galectin Therapeutics Inc

News 26 Oct 2020

Kidney Fibrosis Treatment Market 2020 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis And Forecast To 2026 | Research Report By DataIntelo

Galectin Therapeutics(US) ... ProMetic Life-Sciences Inc(Canada) ... The database of the company is updated on a daily basis to prompt the clients with the latest ...

News 26 Oct 2020

Galectin 3 Market Provides In-Depth Analysis of the Industry, With Current Trends and Future Estimations to Elucidate The Investment Pockets | (2020-2025)

UMR has published a research report on the Galectin 3 market. The report covers comprehensive ... Bristol-Myers Squibb Company Galectin Therapeutics Inc

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Galectin Therapeutics, Inc. 0 6.66 4.56 0 0 0 5.79
Alexion Pharmaceuticals, Inc. 100 93.55 100 0 0 0 100
Vertex Pharmaceuticals Incorporated 0 0 0 0 0 0 0
3SBio Inc. 0 0 0 0 0 0 0
Incyte Corporation 40.27 100 7.19 0 0 0 55.38

Galectin Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Galectin Therapeutics, Inc. $0 $17,737 $-17,751 $149.542M 347
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.301B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $55.268B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.039B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.322B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Galectin Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Galectin Therapeutics, Inc. Post vs Top 4 Industry Competitors


Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries